MAR three-lens brief
Evidence-based stock research on MAR. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 8.9pp over 30 days. · Trading at 91% of its 52-week range — near the top of the band.
- Trading at 91% of its 52-week range — near the top of the band.
- Outperforming SPY by 8.9pp over 30 days.
MAR closed at $367.15 (-0.30%) as of 2026-04-25. Market cap: $97.29B. P/E (trailing) 38.6. Positives: outperforming SPY by 8.9pp over 30 days.. Concerns: trading at 91% of its 52-week range — near the top of the band.. Last quarter: Revenue $6.69B, net income $445.00M, free cash flow $1.67B.
Why three lenses on MAR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine MARacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/MAR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath MAR brief"></iframe>